(PharmaNewsWire.Com, May 29, 2017 ) As per the syndicated report published by Market Data Forecast Europe Ophthalmology Therapeutics Market which is estimated to be USD 5.58 billion in 2016 is poised to reach USD 7.78 billion by 2021, at a CAGR of 6.9% from 2016 to 2021. One of the major factors for ophthalmology market growth is increase cases of diabetic people over old age. Also growing awareness among the masses for regular check-ups for early detection of eye disorders is also leading the market growth. Availability of better techniques and prevalence of diabetes and glaucoma is also influencing the market growth. Although increasing prices for various surgeries and unclear reimbursement policies are hindering the growth of market.
Ophthalmology is the branch of medicine that deals with the anatomy, physiology and diseases of the eyeball. Some of eye disorders that are currently known are colour blindness, retinal diseases, glaucoma, conjunctivitis, refractive errors and blindness.
Due to generic erosion, revenue for glaucoma market will decline in 2018. In the last decade, intraocular lens technology has shifted from refractive technology to diffractive technology with apodization, leading to less frequent and less intense visual side effects.
Europe Ophthalmology Therapeutics Market is segmented based on indication and end-users as mentioned below for attaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
The Europe Ophthalmology market geographically based on the region is segmented as U.K., Germany, Italy, France, and Spain. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well. Germany leads the market due to prevalence of diabetes and glaucoma in the region.
Some of the major companies covered in the report are Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc., Roche Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals. Allergan Inc. has acquired Acquire Glaucoma Treatment Company in order to enhance their minimal invasive eye treatment surgeries.
The Ophthalmology Therapeutics Market study offers the following deliverables:
Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries
Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis
Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses
Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
